EyePoint (EYPT) Other Operating Expenses (2011 - 2026)
EyePoint (EYPT) reported Other Operating Expenses of -$82.4 million for Q1 2026, down 775.62% on a YoY basis from $12.2 million in Q1 2025, and down 119.96% sequentially from $413.1 million in Q4 2025.
EyePoint (EYPT) Other Operating Expenses (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 13 years of Other Operating Expenses data on file, last reported at -$82.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses fell 775.62% year-over-year to -$82.4 million; the trailing twelve-month figure through Mar 2026 stood at $272.6 million (up 254.87% YoY), and the FY2025 full-year result was $223.1 million, up 5705.49% from the prior year.
- Other Operating Expenses eased to -$82.4 million in Q1 2026, from $413.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $413.1 million in Q4 2025 to a low of -$88.6 million in Q4 2024.
- A 5-year average of $8.1 million and a median of $765000.0 in 2024 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses tumbled 2421.89% in 2024 and jumped 566.19% in 2025, its largest moves.
- Tracing EYPT's Other Operating Expenses over 5 years: stood at $39.9 million in 2022, then sank by 222.32% to -$48.8 million in 2023, then slumped by 81.74% to -$88.6 million in 2024, then jumped by 566.19% to $413.1 million in 2025, then tumbled by 119.96% to -$82.4 million in 2026.
- Business Quant data shows EYPT's Other Operating Expenses at -$82.4 million in Q1 2026, $413.1 million in Q4 2025, and -$58.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.43 Mn |
| Dec 31, 2025 | 413.08 Mn |
| Sep 30, 2025 | -58.23 Mn |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | -9.41 Mn |
| Dec 31, 2024 | -88.61 Mn |
| Sep 30, 2024 | -39.03 Mn |
| Jun 30, 2024 | -38.98 Mn |
| Mar 31, 2024 | 765,000.00 |
| Dec 31, 2023 | -48.75 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 7.08 Mn |
| Mar 31, 2023 | 14.26 Mn |
| Dec 31, 2022 | 39.86 Mn |
| Sep 30, 2022 | 8.04 Mn |
| Jun 30, 2022 | 9.23 Mn |
| Mar 31, 2022 | 9.09 Mn |
| Dec 31, 2021 | 18.78 Mn |
| Sep 30, 2021 | 9.81 Mn |
| Jun 30, 2021 | 9.20 Mn |